Market Research Packaging and Labeling (Healthcare) Services Marke | 页面 2

Rampant growth of the pharmaceutical and medical devices industries is the major driver for
growth of the packaging and labeling (healthcare) services market. Certain medical devices are
very delicate and require utmost care when handling, such as microscope slides, glass pipettes
and test tubes, syringes, and several other products. These tools must sometimes travel long
distances using various forms of transport. For example, Solid Bleach Sulfate (SBS) box
partitions are one way to keep devices safe during transit. Packaging plays a pivotal role in
ensuring proper use of the device without causing any damage to it.
Growing demand for anti-counterfeiting drug packaging technology and products is another
major factor fueling market growth. Microbial growth is effectively inhibited by proper
packaging that extends the shelf life of pharmaceutical drugs. As pharmaceutical and medical
devices have to play crucial role in ensuring public health, strict policies are executed, to
determine that the pharmaceuticals packaging fulfil with the highest standards of quality.
Packaging and labelling industry has been affected by many governmental decisions, from the
original Food and Drug Act of 1906 [that banned interstate commerce in misbranded and
adulterated foods, drinks and drugs] to the Dietary Supplement Health and Education Act of
1994 (DSHEA), which established specific labeling requirements for dietary supplements. The
execution of stringent policies has therefore, encouraged pharma companies and medical device
manufacturers to invest on R&D of advanced packaging techniques. Good manufacturing
practices (GMP), good clinical practices (GCP) and good laboratory practices (GLP) and the
responsibility on the regulatory bodies to ensure a healthy supply of quality drugs at affordable
prices to the Indian masses.
Browse Detail Report @
https://www.coherentmarketinsights.com/ongoing-insight/packaging-and-labeling-
services-market-210
Despite being facilitated by favorable government regulations, complicated registration and
approval processes are some of the expected factors which hamper packaging and labeling
market growth. For example, under the Poison Prevention Packaging Act in 1970, the
Consumer Product Safety Commission (CPSC) has the authority to require that packaging for
possibly dangerous products including oral forms of most prescription and over the counter
(OTC) drugs and iron containing dietary supplements incorporate child strong features to
prevent serious personal injury.
This market is expected to extensively gain from the rising adoption of nano-enabled packaging
in the pharmaceutical industry. Nano-enabled packaging uses nano-materials with diameter less